Header Logo

Connection

Bette Caan to Genotype

Back to Details
This is a "connection" page, showing publications Bette Caan has written about Genotype.
Bette Caan
Connection Strength
1.168
Genotype
  1. Genetic variation in the transforming growth factor-ß-signaling pathway, lifestyle factors, and risk of colon or rectal cancer. Dis Colon Rectum. 2012 May; 55(5):532-40.
    View in: PubMed
    Score: 0.100
  2. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019 01; 51(1):76-87.
    View in: PubMed
    Score: 0.039
  3. Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants. PLoS One. 2016; 11(7):e0157521.
    View in: PubMed
    Score: 0.033
  4. CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. Br J Cancer. 2016 Jan 19; 114(2):221-9.
    View in: PubMed
    Score: 0.032
  5. A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival. J Natl Cancer Inst. 2015 Sep; 107(9).
    View in: PubMed
    Score: 0.031
  6. Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1024-31.
    View in: PubMed
    Score: 0.031
  7. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA. 2015 Mar 17; 313(11):1133-42.
    View in: PubMed
    Score: 0.030
  8. Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies. Cancer Epidemiol Biomarkers Prev. 2015 Jan; 24(1):198-205.
    View in: PubMed
    Score: 0.030
  9. Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci. Cancer Epidemiol Biomarkers Prev. 2014 Sep; 23(9):1824-33.
    View in: PubMed
    Score: 0.029
  10. Genome-wide diet-gene interaction analyses for risk of colorectal cancer. PLoS Genet. 2014 Apr; 10(4):e1004228.
    View in: PubMed
    Score: 0.029
  11. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control. 2013 Dec; 24(12):2059-75.
    View in: PubMed
    Score: 0.028
  12. Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):2037-46.
    View in: PubMed
    Score: 0.027
  13. African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative. Am Heart J. 2013 Sep; 166(3):566-72.
    View in: PubMed
    Score: 0.027
  14. Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res. 2013 Apr; 57(4):721-34.
    View in: PubMed
    Score: 0.026
  15. Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res. 2012 Apr 15; 72(8):2036-44.
    View in: PubMed
    Score: 0.025
  16. Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment. Nutr Cancer. 2011 Nov; 63(8):1226-34.
    View in: PubMed
    Score: 0.024
  17. Genetic variation in bone morphogenetic protein and colon and rectal cancer. Int J Cancer. 2012 Feb 01; 130(3):653-64.
    View in: PubMed
    Score: 0.023
  18. Variation in the CYP19A1 gene and risk of colon and rectal cancer. Cancer Causes Control. 2011 Jul; 22(7):955-63.
    View in: PubMed
    Score: 0.023
  19. Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer. 2011; 63(3):357-66.
    View in: PubMed
    Score: 0.023
  20. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer. 2011 Jun 01; 128(11):2726-34.
    View in: PubMed
    Score: 0.023
  21. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-ß-signaling pathway. Carcinogenesis. 2011 Mar; 32(3):318-26.
    View in: PubMed
    Score: 0.023
  22. Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3131-9.
    View in: PubMed
    Score: 0.022
  23. Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. Cancer Res. 2010 Feb 15; 70(4):1479-85.
    View in: PubMed
    Score: 0.021
  24. Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2010 Jan; 19(1):74-9.
    View in: PubMed
    Score: 0.021
  25. Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3384-8.
    View in: PubMed
    Score: 0.021
  26. Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2009 Nov; 18(11):3079-85.
    View in: PubMed
    Score: 0.021
  27. Tumor markers and rectal cancer: support for an inflammation-related pathway. Int J Cancer. 2009 Oct 01; 125(7):1698-704.
    View in: PubMed
    Score: 0.021
  28. Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Sep; 18(9):2540-8.
    View in: PubMed
    Score: 0.021
  29. Genetic variation in calcium-sensing receptor and risk for colon cancer. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2755-65.
    View in: PubMed
    Score: 0.019
  30. Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut. 2009 May; 58(5):661-7.
    View in: PubMed
    Score: 0.019
  31. Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer. 2008 Apr 01; 122(7):1611-7.
    View in: PubMed
    Score: 0.019
  32. CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2752-5.
    View in: PubMed
    Score: 0.018
  33. IL6 genotypes and colon and rectal cancer. Cancer Causes Control. 2007 Dec; 18(10):1095-105.
    View in: PubMed
    Score: 0.018
  34. Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control. 2007 Mar; 18(2):153-63.
    View in: PubMed
    Score: 0.017
  35. Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer. Int J Cancer. 2006 Jun 15; 118(12):3140-6.
    View in: PubMed
    Score: 0.017
  36. Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev. 2006 Apr; 15(4):744-9.
    View in: PubMed
    Score: 0.016
  37. Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer. 2006; 55(1):35-43.
    View in: PubMed
    Score: 0.016
  38. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2936-42.
    View in: PubMed
    Score: 0.016
  39. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2005 Nov; 14(11 Pt 1):2509-16.
    View in: PubMed
    Score: 0.016
  40. MTHFR variants reduce the risk of G:C->A:T transition mutations within the p53 tumor suppressor gene in colon tumors. J Nutr. 2005 Oct; 135(10):2462-7.
    View in: PubMed
    Score: 0.016
  41. Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1802-9.
    View in: PubMed
    Score: 0.016
  42. Energy balance, insulin-related genes and risk of colon and rectal cancer. Int J Cancer. 2005 May 20; 115(1):148-54.
    View in: PubMed
    Score: 0.015
  43. Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1224-9.
    View in: PubMed
    Score: 0.015
  44. Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1350-2.
    View in: PubMed
    Score: 0.015
  45. The CYP1A1 genotype may alter the association of meat consumption patterns and preparation with the risk of colorectal cancer in men and women. J Nutr. 2005 Feb; 135(2):179-86.
    View in: PubMed
    Score: 0.015
  46. Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control. 2004 Nov; 15(9):863-72.
    View in: PubMed
    Score: 0.015
  47. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer. 2004 Sep 20; 111(5):750-6.
    View in: PubMed
    Score: 0.015
  48. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1206-14.
    View in: PubMed
    Score: 0.014
  49. Meat consumption patterns and preparation, genetic variants of metabolic enzymes, and their association with rectal cancer in men and women. J Nutr. 2004 Apr; 134(4):776-84.
    View in: PubMed
    Score: 0.014
  50. Interplay between dietary inducers of GST and the GSTM-1 genotype in colon cancer. Int J Cancer. 2000 Sep 01; 87(5):728-33.
    View in: PubMed
    Score: 0.011
  51. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 1998 Dec; 7(12):1079-84.
    View in: PubMed
    Score: 0.010

© 2024 Kaiser Permanente